New WHO guidance for country validation of viral hepatitis B and C elimination

Lancet Gastroenterol Hepatol. 2021 Oct;6(10):778-780. doi: 10.1016/S2468-1253(21)00267-3. Epub 2021 Aug 9.

Authors

Philippa Easterbrook¹, Niklas Luhmann², Morkor Newman², Nick Walsh², Olufunmilayo Lesi², Meg Doherty²

Affiliations

¹ Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, 1211, Switzerland. Electronic address: easterbrookp@who.int.
² Department of Global HIV, Hepatitis and STI Programmes, World Health Organization, Geneva, 1211, Switzerland.

PMID: 34384530
DOI: 10.1016/S2468-1253(21)00267-3

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Child, Preschool
Disease Eradication / statistics & numerical data*
Guideline Adherence
Health Planning Guidelines
Health Services Accessibility
Hepatitis B / epidemiology
Hepatitis B / prevention & control*
Hepatitis C / epidemiology
Hepatitis C / prevention & control*
Humans
Incidence
Infant
Mortality / trends
Validation Studies as Topic
World Health Organization / organization & administration*

Grants and funding

001/WHO_/World Health Organization/International